Azilect
Rasagiline
Rasagiline is a propargylamine-based medication indicated to treat Parkinson’s Disease.
Status: Completed
FDA Approved
Vimpat
Lacosamide
Lacosamide (Vimpat) is an oral medication indicated for the treatment of partial-onset seizures.
Status: Completed
FDA Approved
Allergan
UbreIvy
UbreIvy is an oral medication made for immediate treatment of migraines.
Status: Completed
FDA Approved
ACADIA
Pimavanserin
Pimavanserin is indicated to treat psychosis in patients with Parkinson’s Disease.
Status: Completed
FDA Approved
Novartis
Exelon Patch
The Exelon Patch is indicated for patients with mild to severe Alzheimer’s Disease to improve nerve cells function.
Status: Completed
FDA Approved
PASSAGE
Fingolimod
Fingolimod (KESIMPTA) is an oral medication indicated for the treatment of relapsing multiple sclerosis.
Status: Completed
FDA Approved
PROMISE
Eptinezumab
Eptinezumab (ALD403) is a CGRP antagonist for the prophylaxis of frequent episodic migraines.
Status: Completed
FDA Approved
TRIUMPH
Emgality
Emgality (galcanezumab) is a preventive treatment for migraines.
Status: Completed
FDA Approved
EMBARK
Aducanumab
Aducanumab is an anti-amyloid beta antibody made for patients with Alzheimer’s Disease.
Status: Completed
FDA Approved
